- Home
- Products
- Customized ADCs
- CD33
- Anti-CD33-AcBut-Calicheamicin ADC-5
Anti-CD33-AcBut-Calicheamicin ADC-5 (CAT#: ADC-W-464)
This ADC product is comprised of an Anti-CD33 antibody (clone hP67.6) conjugated via a AcBut linker to Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, Calicheamicin binds to DNA, causes DNA damage.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- hP676
- Similar to
- gemtuzumab ozogamicin
- Name
- CD33
- Alternative Names
- CD33; CD33 molecule; p67; SIGLEC3; SIGLEC-3; myeloid cell surface antigen CD33; gp67; CD33 antigen (gp67); sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3;
- Target Entrez Gene ID
- 945
- Target UniProt ID
- P20138
- Overview
- CD33 or Siglec-3 is a transmembrane receptor expressed on cells of myeloid lineage. It is usually considered myeloid-specific, but it can also be found on some lymphoid cells. It binds sialic acids, therefore is a member of the SIGLEC family of lectins.
- Overview
- Anti-CD33 lgG4κ Antibody, clone # hP676
- Generic name
- gemtuzumab
- Clone #
- hP676
- Species Reactivity
- Human
- Name
- AcBut (4-(4-acetylphenoxy)butanoic acid)
- Description
- Acid-labile linkers, belonging to chemically cleavable linkers, are designed based on a pH-dependent release mechanism and remain intact during systemic circulation in the blood's neutral pH environment (pH 7.3–7.5) but to undergo hydrolysis and release drug once the ADC is internalized into mildly acidic endosomal (pH 5.0–6.5) and lysosomal (pH 4.5–5.0) compartments of the cell.
- Name
- Calicheamicin
- Description
- Calicheamicin,produced by prokaryotic microorganisms, are a group of DNA cleaving agents with similar structure that binds in the minor grove of DNA in a relatively sequence-specific manner.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-FOLH1 (Capromab)-SPDB-DM4 ADC (CAT#: ADC-W-1161)
- Anti-TAG-72 (Minretumomab)-SPDB-DM4 ADC (CAT#: ADC-W-1989)
- Anti-IGHE (Quilizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1279)
- Anti-MS4A1 (Technetium (99mTc) nofetumomab merpentan)-SPDB-DM4 ADC (CAT#: ADC-W-1587)
- Anti-ITGB3 (Tadocizumab)-SPDB-DM4 ADC (CAT#: ADC-W-2605)
- Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2568)
- Anti-APP (Gantenerumab)-SMCC-DM1 ADC (CAT#: ADC-W-680)
- Anti-LTA (Pateclizumab)-SMCC-DM1 ADC (CAT#: ADC-W-1532)
- Anti-TNFSF4 (Oxelumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1921)
- Anti-APP (Gantenerumab)-MC-MMAF ADC (CAT#: ADC-W-682)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-464. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-817 | Anti-CD33 (Lintuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2541 | Anti-CD33 (Gemtuzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-815 | Anti-CD33 (Lintuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-492 | Anti-CD33-Mc-VC-SGD-1882 ADC-7 | mc-VC (maleimidocaproyl-valine-alanine) | SGD-1882 |
| ADC-W-480 | Anti-CD33-SPDB-DM4 ADC-6 | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-461 | Anti-CD22-AcBut-CalichDMH ADC-10 | AcBut (4-(4-acetylphenoxy)butanoic acid) | CalichDMH |
| CAT# | Product Name | Linker | Payload |
| ADC-W-008 | Anti-TPBG-AcBut-calicheamicin ADC-1 | AcBut [-(4' acetyl phenoxy) butanoic acid] | calicheamicin |
| WJY-0423-LS106 | Protein A-Calicheamicin ADC | Cleavable linkers | Calicheamicin |
| ADC-W-357 | Anti-CD33-AcBut-Calicheamicin ADC-4 | AcBut [-(4' acetyl phenoxy) butanoic acid] | calicheamicin |
| ADC-W-332 | Anti-CD22-AcBut-Calicheamicin ADC-7 | AcBut [-(4' acetyl phenoxy) butanoic acid] | calicheamicin |
| ADC-W-338 | Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC | hydrazone | calicheamicin |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
